Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-906-4 | CAS number: 3277-26-7
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02.12.1991 to 10.01.1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
- Principles of method if other than guideline:
- Human Patch test to determine whether the test material was capable of sensitising the skin of humans under controlled patch test conditions.
- GLP compliance:
- not specified
- Type of study:
- patch test
- Justification for non-LLNA method:
- An LLNA study was not performed because there is an existing reliable study for skin sensitisation using Human Patch test method. Furthermore, the LLNA test method is not considered to be suitable for substances that contain silicon. Please refer to the attached document for further details.
Test material
- Reference substance name:
- Hexamethyldisiloxane
- EC Number:
- 203-492-7
- EC Name:
- Hexamethyldisiloxane
- Cas Number:
- 107-46-0
- Molecular formula:
- C6H18OSi2
- IUPAC Name:
- hexamethyldisiloxane
Constituent 1
In vivo test system
Test animals
- Species:
- human
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Not applicable
- Age at study initiation: 18 to 78 years
- Weight at study initiation: Not applicable
- Housing: Not applicable
- Diet (e.g. ad libitum): Not applicable
- Water (e.g. ad libitum): Not applicable
- Acclimation period: Not applicable
ENVIRONMENTAL CONDITIONS: Not applicable
IN-LIFE DATES: From: 02.12.1991 to 10.01.1992
Study design: in vivo (non-LLNA)
Induction
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- Undiluted
Challenge
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- Undiluted
- No. of animals per dose:
- 100
- Details on study design:
- 1st application: Induction undiluted semiocclusive
(0.2ml)
2nd application: Challenge undiluted semiocclusive (0.2ml)
One hundred subjects were employed in this study. Semi-occlusive, 2 cm x 2 cm Webril pad patches were applied to the infrascapular area of the back, either to the right or left of the midline. The induction phase consisted of application of the test material every 48 hours for a total of nine applications (applications made on Friday were not evaluated until Monday, prior to the re-application of test material) with the occlusive patch being removed after 24 hours. The test sites were evaluated prior to each application. Following the ninth evaluation, the subjects were dismissed for a 14-day rest period. After the rest period, identical patches were applied to sites previously unexposed to test material. These patches were removed 24 hours after application and were evaluated 48 hours and 72 hours after application. Each person was considered a complete case and used for evaluation of the material if they had six or more applications and subsequent readings during the first phase and at least one reading during the final phase.
Test Subjects
* 11 males and 97 females.
Following the second application of the test material, a significant number of subjects developed superficial epidermal erosion. It was decided to change the occlusive patch condition to semi-occlusive, applying the material to the same site beginning with the third application. - Challenge controls:
- None
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- No positive control.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.2 ml undiluted
- No. with + reactions:
- 0
- Total no. in group:
- 100
- Clinical observations:
- Under the conditions employed in this study, there was no evidence of skin sensitization to the test material.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 0.2 ml undiluted
- No. with + reactions:
- 0
- Total no. in group:
- 100
- Remarks on result:
- other:
- Group:
- positive control
- Remarks on result:
- other: No positive control was used.
- Group:
- negative control
- Remarks on result:
- other: Not specified
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a well conducted human patch test hexamethyldisiloxane was not sensitising to the skin of human volunteers.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
